Release Date: 29/05/09 12:57 Summary: Director Resignation and Appendix 3Z Price Sensitive: No Download Document 317.01KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%